Senores Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
1,361.25
6.7 (0.49%)
BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 1.09 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
180.21
175.19
170.95
161.76
137.99
114.21
103.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
180.21
175.19
170.95
161.76
137.99
114.21
103.02
Raw Material Cost
31.15
27.05
36.96
46.09
29.38
20.94
23.10
Purchase of Finished goods
34.01
35.71
37.87
11.00
27.55
29.06
22.13
(Increase) / Decrease In Stocks
0.56
3.46
-7.81
-0.01
4.43
7.46
-4.53
Employee Cost
29.91
30.32
30.66
29.63
21.65
14.63
19.01
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
30.82
31.16
22.87
25.54
20.82
22.68
17.62
Total Expenditure (Excl Depreciation)
126.45
127.70
120.55
112.25
103.83
94.77
77.33
Operating Profit (PBDIT) excl Other Income
53.76
47.49
50.40
49.51
34.16
19.44
25.69
Other Income
2.81
17.67
7.39
5.41
3.36
11.77
5.16
Operating Profit (PBDIT)
56.57
65.16
57.79
54.92
37.52
31.21
30.85
Interest
7.17
8.46
5.33
6.19
5.04
5.30
6.16
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
49.40
56.70
52.46
48.73
32.48
25.91
24.69
Depreciation
9.94
9.30
7.86
8.09
5.99
5.23
4.20
Profit Before Tax
39.46
47.40
44.60
40.64
26.49
20.68
20.49
Tax
9.01
10.73
11.02
10.52
5.31
2.71
4.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.45
36.67
33.58
30.12
21.18
17.97
16.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.45
36.67
33.58
30.12
21.18
17.97
16.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.27
5.06
1.92
-2.26
1.45
0.14
-0.75
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.72
31.61
31.66
32.38
19.73
17.83
17.18
Equity Capital
46.05
46.05
46.05
46.05
46.05
46.05
46.05
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.67
6.86
6.88
7.03
4.28
3.87
3.73
Diluted Earnings per share
6.6
7.96
7.29
6.54
4.6
3.81
5.04
Operating Profit Margin (Excl OI)
29.83%
27.11%
29.48%
32.28%
26.22%
17.02%
24.94%
Gross Profit Margin
27.41%
32.36%
30.69%
31.77%
24.93%
22.69%
23.97%
PAT Margin
16.9%
20.93%
19.64%
19.64%
16.25%
15.73%
15.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 2.87% vs 2.48% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -2.82% vs -0.16% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 13.20% vs -5.77% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -15.25% vs 58.72% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Senores Pharma. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
180.21
584.79
-404.58
-69.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
180.21
584.79
-404.58
-69.18%
Raw Material Cost
31.15
148.93
-117.78
-79.08%
Purchase of Finished goods
34.01
41.78
-7.77
-18.60%
(Increase) / Decrease In Stocks
0.56
14.90
-14.34
-96.24%
Employee Cost
29.91
109.30
-79.39
-72.63%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
30.82
163.52
-132.70
-81.15%
Total Expenditure (Excl Depreciation)
126.45
478.43
-351.98
-73.57%
Operating Profit (PBDIT) excl Other Income
53.76
106.36
-52.60
-49.45%
Other Income
2.81
49.89
-47.08
-94.37%
Operating Profit (PBDIT)
56.57
156.25
-99.68
-63.80%
Interest
7.17
1.55
5.62
362.58%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
49.40
154.70
-105.30
-68.07%
Depreciation
9.94
14.35
-4.41
-30.73%
Profit Before Tax
39.46
140.35
-100.89
-71.88%
Tax
9.01
36.95
-27.94
-75.62%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
30.45
103.40
-72.95
-70.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
30.45
103.40
-72.95
-70.55%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.27
0.00
-0.27
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.72
103.40
-72.68
-70.29%
Equity Capital
46.05
16.28
29.77
182.86%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.67
6.35
0.32
5.04%
Diluted Earnings per share
6.60
6.35
0.25
3.94%
Operating Profit Margin (Excl OI)
29.83%
18.19%
0.00
11.64%
Gross Profit Margin
27.41%
26.45%
0.00
0.96%
PAT Margin
16.90%
17.68%
0.00
-0.78%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 180.21 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 2.87% vs 2.48% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 30.60% vs 71.65% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 30.72 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -2.82% vs -0.16% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 55.70% vs 83.88% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 53.76 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 13.20% vs -5.77% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 57.38% vs 60.23% in Jun 2025

Quarterly - Interest
Interest 7.17 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -15.25% vs 58.72% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 42.26% vs 4.56% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.83%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025